's  Instablog
Send Message is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more . Follow on Twitter... More
My company:
Investor Ideas
My blog:
Clean Energy Stocks
  • Biodefense Stocks Snapshot; (OTCBB: AEMD), (NasdaqCM: CBLI ) ,(NYSE Amex: PIP), (NasdaqGM: SIGA ) 0 comments
    Mar 22, 2011 12:32 PM | about stocks: PIP, CBLI, SIGA
    Biodefense Stocks Snapshot; (OTCBB: AEMD), (NasdaqCM: CBLI ) ,(NYSE Amex: PIP), (NasdaqGM: SIGA )
    Biological Warfare Potential Threats and Radiation Leaks Bringing Attention to Biodefense Stocks  
    Point Roberts, WA-, a leader in investor sector research including biotech and biodefense stocks looks at some of the biotech stocks developing technologies and products to deal with  news headlines of ‘radiation leaks and biological warfare’. Biodfense stocks have not been in the investor spotlight in recent years as Bioterrorism fears subsided and new issues took the forefront for Wall Street.
    A major trigger for the sector are the global concerns and fears that Libyan leader, Colonel Muammar Gaddafi will potentially use biological and chemical weapons.
    In a recent article on Daily Finance entitled “Inside Wall Street: Looking to the Bio-Defense Sector as Nuclear Fears Mount”, notes - The sector attracted a lot of interest after 9/11 and a number of companies emerged to develop protective biodefense drugs and products. But with the waning of dark headlines about terrorist threats, investors have tended to put them on their low-priority list.
    That may be about to change
    Following 911, Project Bioshield Act was passed by Congress in 2004 calling for $5 billion for purchasing vaccines to be used in the event of a bioterrorist attack. Biotech companies continued to move forward with solutions as investors moved on to other sectors.
    According to a recent article in, “Bioterrorism, in my view, is the most serious and likely threat to our national security,"Simon said, reports.
    Chairman and CEO of  Aethlon Medical, Inc.(OTCBB: AEMD) recently updated his shareholders regarding their biodfense efforts in letter March 15th .    
    “As we advance our Hepatitis-C (HCV) treatment studies in India, we have also been active in our efforts to benefit from new government policies aimed at protecting U.S. civilian and military populations from bioterror and pandemic threats.”
    Mr. Joyce went on to say, :Earlier this year, we were honored to be invited by The Department of Health and Humans Services (NYSE:HHS) to present our Hemopurifier® as a broad-spectrum platform technology to multi-agency health officials on January 12th at the Washington Convention Center. Since this presentation, our bioterror and pandemic threat initiative has led to follow-on meetings and presentations, including a formal presentation to the Biomedical Advanced Research and Development Authority (BARDA) on February 15th. “
    PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, reported last month “ that new pharmacokinetic data from the Company's Valortim® anthrax anti-toxin program were presented at the 9th Annual ASM Biodefense and Emerging Diseases Research Meeting, held in Washington, DC, February 6-9, 2011. The data were presented by Dr. Elizabeth Leffel, Director of Non-Clinical Sciences for PharmAthene, in a poster presentation entitled, "Pharmacokinetics of a Monoclonal Anthrax Anti-Toxin Antibody in Healthy and Infected Cynomolgus Macaques."
    Biodefense Stocks  Sector Snapshot
    Aethlon Medical (OTCBB: AEMD) trading at $0.14
    Cleveland BioLabs (NasdaqCM: CBLI ) trading at $7.35, up 0.19 (2.65%) 10:10AM EDT
    Emergent Biosolutions, Inc. Com (NYSE: EBS ) trading at $23.59, up 0.02 (0.08%) 10:33AM EDT
    PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, trading at $3.42, up 0.01 (0.29%) 10:31AM EDT
    Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) trading at $0.33
    Siga Technologies (NasdaqGM: SIGA ) trading at $11.83, down   0.28 (2.31%) 10:35AM EDT
    Soligenix, Inc. (OTCBB:SNGX) trading at $0.20
    Research more Biodfense stocks at
    Market Snapshot
    Dow 12,027.75 -8.78 -0.07% 
    NASDAQ 2,690.32 -1.77 -0.07% 
    S&P 500 1,296.45 -1.93 -0.15% 
    10 Yr Bond(%) 3.3390% +0.0160 
    Oil 102.45 +0.13 +0.13% 
    Gold 1,426.20 0.00 0.00
    Biodefense Company Snapshot
    Aethlon Medical ( OTCBB:AEMD)
    At Aethlon Medical, we create revolutionary devices to address infectious disease and cancer. Our devices are designed to be novel platform solutions that fill therapeutic voids or aid in disease diagnosis and monitoring.
    Our Hemopurifier® is the first medical device to selectively target the removal of infectious viruses and immunosuppressive proteins from the entire circulatory system. We recently discovered that our Hemopurifier® captures tumor-secreted exosomes that suppress the immune system of those afflicted with cancer. Prior to this discovery, a therapeutic strategy to directly inhibit or reverse the immunosuppressive destruction caused by exosomes did not exist in cancer care. By eliminating this mechanism, we believe our Hemopurifier® can fill an unmet clinical need and provide the benefit of an immune-based therapy without adding drug toxicity or interaction risks to established and emerging treatment strategies.
    James A. Joyce
    Chairman, CEO
    858.459.7800 x301
    Visit the Aethlon Medical ( OTCBB:AEMD) showcase page on
    Get added to the company’s news alerts:
 is a leading global investor and industry research resource portal specialized in sector investing, including biotech stocks with its portal
    Disclaimer/ Disclosure : The is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech,  biodefense and defense stock on ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011     
    Aethlon Medical (OTCBB:AEMD) :Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements.  
    800-665-0411 -
    Source -
    Stocks: PIP, CBLI, SIGA
Back To's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.